ALPK2 and urinary bladder carcinoma: Next, we demonstrated that bladder cancer cells exhibiting downregulated expression levels of ALPK2 (shALPK2) also showed significantly slower proliferation rates than the shCtrl group (P < 0.05, Figs. 2A and S2A).